Word

GAMHALTY

Status

Registered

Status Code

700

Status Date

Tuesday, July 3, 2018

Serial Number

87283837

Registration Number

5505934

Registration Date

Tuesday, July 3, 2018

Mark Type

4000

Filing Date

Thursday, December 29, 2016

Published for Opposition

Tuesday, April 17, 2018

Trademark Owner History

NovImmune SA - Original Registrant

Classifications

5 Pharmaceutical and biological preparations to treat immunological, inflammatory, oncological, viral, infectious, neurological, musculoskeletal, respiratory, and dermatological diseases, disorders and conditions; pharmaceutical and biological preparations based on polypeptides, superantigens, biomarkers and antibodies to treat immunological, inflammatory, oncological, viral, infectious, neurological, musculoskeletal, respiratory, and dermatological diseases, disorders and conditions; Pharmaceutical and biological preparations and immunotherapies being medical preparations for stimulating the immune response, all for use in the diagnosis, prevention, management and treatment of immunological, inflammatory, oncological, viral, infectious, neurological, musculoskeletal, respiratory, and dermatological diseases, disorders and conditions; therapeutic and diagnostic agents, preparations and substances for medical purpose for use in therapies for immunological, inflammatory, oncological, viral, infectious, neurological, musculoskeletal, respiratory, and dermatological diseases, disorders and conditions; biochemical substance, polypeptides, antibodies, biomarkers and superantigens for use in diagnoses and therapies for immunological, inflammatory, oncological, viral, infectious, neurological, musculoskeletal, respiratory, and dermatological diseases, disorders and conditions; engineered cell therapies, namely engineered T cells, immune cells, and antibodies for medical purposes; diagnostic biomarker reagents for medical purposes; diagnostic test kits consisting primarily of biomarkers for medical purposes; biochemical test kits comprised of assays and reagents for medical, diagnostic and therapeutic purposes

1 Biochemicals, namely, polypeptides, superantigens, biomarkers and antibodies for medical and scientific research; cells, cell extracts and components of cells for medical and scientific research; diagnostic agents for medical and scientific research; diagnostic biomarker reagent for biomarker reagents for medical and scientific research; diagnostic test kits consisting primarily of biomarkers for medical and scientific research; biochemical test kits consisting of assays and reagents for medical and scientific research purposes

Trademark Events

Jul 3, 2023

Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed

Apr 20, 2023

Applicant/Correspondence Changes (Non-Responsive) Entered

Apr 20, 2023

Teas Change Of Correspondence Received

Apr 20, 2023

Teas Change Of Domestic Representatives Address

Apr 20, 2023

Teas Withdrawal Of Attorney Received-Firm Retains

Apr 20, 2023

Attorney/Dom.Rep.Revoked And/Or Appointed

Apr 20, 2023

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Apr 20, 2023

Teas Change Of Owner Address Received

Jul 3, 2018

Registered-Principal Register

Apr 17, 2018

Official Gazette Publication Confirmation E-Mailed

Apr 17, 2018

Published For Opposition

Mar 28, 2018

Notification Of Notice Of Publication E-Mailed

Mar 13, 2018

Approved For Pub - Principal Register

Mar 13, 2018

Teas/Email Correspondence Entered

Mar 12, 2018

Correspondence Received In Law Office

Mar 12, 2018

Teas Response To Office Action Received

Nov 2, 2017

Notification Of Non-Final Action E-Mailed

Nov 2, 2017

Non-Final Action E-Mailed

Nov 2, 2017

Non-Final Action Written

Oct 12, 2017

Teas/Email Correspondence Entered

Oct 12, 2017

Correspondence Received In Law Office

Oct 10, 2017

Assigned To Lie

Sep 27, 2017

Teas Response To Office Action Received

Mar 27, 2017

Notification Of Non-Final Action E-Mailed

Mar 27, 2017

Non-Final Action E-Mailed

Mar 27, 2017

Non-Final Action Written

Mar 27, 2017

Assigned To Examiner

Jan 10, 2017

New Application Office Supplied Data Entered

Jan 2, 2017

New Application Entered